BioNxt Solutions Inc. (OTCMKTS:BNXTF) Short Interest Up 60.0% in November

BioNxt Solutions Inc. (OTCMKTS:BNXTF) was the recipient of a significant increase in short interest in the month of November. As of November 15th, there was short interest totalling 1,600 shares, an increase of 60.0% from the October 31st total of 1,000 shares. Based on an average daily volume of 8,300 shares, the days-to-cover ratio is presently 0.2 days.

BioNxt Solutions Stock Performance

Shares of BioNxt Solutions stock opened at $0.18 on Friday. BioNxt Solutions has a 52-week low of $0.11 and a 52-week high of $0.57. The company’s 50 day moving average price is $0.18 and its 200-day moving average price is $0.20.

BioNxt Solutions (OTCMKTS:BNXTF) last announced its quarterly earnings results on Wednesday, August 28th. The company reported ($0.01) earnings per share (EPS) for the quarter.

BioNxt Solutions Company Profile

BioNxt Solutions Inc engages in generation drug formulations and delivery system in Korea, Austria, Germany, and Switzerland. The company provides drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications. It offers point-of-care diagnostic, including covid-19 PCR diagnostic kit, a covid rapid test; peri-implantitis Oral Biosensor, allows early detection of infection associated with dental implants; and H1N1 (Swine Flu) and H5N1 (Avian Flu) oral biosensors for early detection of highly pathogenic influenza a strains.